arrow
L

Leslie Lehmann

egyptian knowledge bank (ekb)
H指数:45
被引数:6,479

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Allogeneic HSCT outcomes and impact of defibrotide prophylaxis on SOS after inotuzumab in pediatric B-ALL

异基因HSCT结局及defibrotide预防在inotuzumab治疗后儿童B-ALL患者中继发OS的影响

2026-07-200
OA
Central Venous Catheter Removal After Hematopoietic Stem Cell Transplant: A Review and Perspective

造血干细胞移植后中心静脉导管拔除:综述与展望

2025-11-010
PRE
Allogeneic Hematopoietic Stem Cell Transplantation in Adolescents and Young Adults With Acute Lymphoblastic Leukemia-A Retrospective, Dual-Center Study

异基因造血干细胞移植在青少年和年轻急性淋巴细胞白血病患者中的应用——一项回顾性、双中心研究

2025-10-010
OAAI
Treating and triggering hyperinflammation: tackling hemophagocytic lymphohistiocytosis and HLH-like syndromes in the pediatric cell therapy and critical care setting

治疗和诱导高炎症反应:在儿科细胞疗法和重症监护环境中应对噬血细胞性淋巴组织细胞增多症及HLH样综合征

2025-09-200
OAAI
Multicenter Study on Caregiver Experiences in Pediatric Hematopoietic Stem Cell Transplantation: Part II. Treatment Challenges, Communication Barriers, and Caregiver-Driven Approaches to Mitigation

多中心研究:儿科造血干细胞移植中照护者体验(第二部分:治疗挑战、沟通障碍以及照护者驱动的缓解措施)

2025-05-100
PRE
Engraft: A Collaborative Learning Health Network for Enhanced Transplant and Cellular Therapy Outcomes
2025-03-010
PRE
Impact of Race and Ethnicity on Outcomes After Umbilical Cord Blood Transplantation

种族和民族对脐血移植后结局的影响

2024-10-010
PRE
Racial and Socioeconomic Disparities in Long-Term Outcomes in ≥1 Year Allogeneic Hematopoietic Cell Transplantation Survivors: A CIBMTR Analysis

≥ 1年异基因造血干细胞移植幸存者长期结果的种族和社会经济差异: CIBMTR分析

2023-11-016
PRE